<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Resources | Tanigawa Lab</title><link>https://tanigawalab.org/tags/resources/</link><atom:link href="https://tanigawalab.org/tags/resources/index.xml" rel="self" type="application/rss+xml"/><description>Resources</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en</language><lastBuildDate>Thu, 26 Oct 2023 00:00:00 +0000</lastBuildDate><image><url>https://tanigawalab.org/media/logo_hu_6ec5cb994dd998e6.png</url><title>Resources</title><link>https://tanigawalab.org/tags/resources/</link></image><item><title>Power of inclusion: Enhancing polygenic prediction with admixed individuals</title><link>https://tanigawalab.org/publications/2023/ipgs/</link><pubDate>Thu, 26 Oct 2023 00:00:00 +0000</pubDate><guid>https://tanigawalab.org/publications/2023/ipgs/</guid><description>&lt;p&gt;
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/2023/ipgs/ipgs-1.png" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
Polygenic score (PGS), a statistical approach to estimating genetic predisposition on traits, attracted substantial research interest. The current PGS models show limited transferability across populations, and there are a number of great new methods to address this challenge.
We propose inclusive polygenic score (iPGS), a PGS training strategy to capture ancestry-shared genetic effects by analyzing individuals across the continuum of genetic ancestry. We work directly on the individual-level data without relying on GWAS results and LD references.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/2023/ipgs/ipgs-2.png" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
We tested our approach across 33 simulation configurations and 60 quantitative traits in UK Biobank. We see increased power by including ancestry-diverse individuals compared to our baseline model trained only on white British individuals.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/2023/ipgs/ipgs-3.png" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/2023/ipgs/ipgs-4.png" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
We observe improvements in performance for all population groups. The average improvement across the 60 traits was 60.8% for African, 11.6% for South Asian, 7.3% for non-British White, 4.8% for White British, and 17.8% for other diverse individuals.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/2023/ipgs/ipgs-5.png" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/2023/ipgs/ipgs-6.png" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
To consider ancestry-dependent genetic effects on top of ancestry-shared effects, we developed iPGS+refit. We used a heterogeneity test in GWAS meta-analysis and identified genetic variants with heterogeneous associations, such as the ACKR1 locus for neutrophil count.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/2023/ipgs/ipgs-7.png" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
Our iPGS+refit starts with one ancestry-shared component (iPGS) and adds ancestry-dependent effects using a relatively small number of genetic loci, facilitating better interpretation. We used hematological traits to show improved predictive performance.&lt;/p&gt;
&lt;p&gt;We compared our model with PRS-CSx, a commonly-used multi-ancestry PGS method from summary statistics from multiple population groups and ancestry-matched reference panels. In our analysis, our iPGS/iPGS+refit models showed competitive or improved performance.&lt;/p&gt;
&lt;p&gt;We thank UK Biobank, its participants, amazing collaborators and colleagues, as well as funding.&lt;/p&gt;
&lt;p&gt;You can browse and download our iPGS models at our iPGS browser. Taking advantage of the sparsity of our PGS models, it offers direct integration with HaploReg and GREAT.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/2023/ipgs/ipgs-8.png" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
&lt;/p&gt;</description></item><item><title>WhichTF is dominant in your open chromatin data?</title><link>https://tanigawalab.org/publications/2022/whichtf/</link><pubDate>Tue, 30 Aug 2022 00:00:00 +0000</pubDate><guid>https://tanigawalab.org/publications/2022/whichtf/</guid><description>&lt;p&gt;We develop an ontology-guided approach to ranking tissue-/cell-type-specific transcription factors (TFs) from chromatin accessibility data.&lt;/p&gt;</description></item><item><title>Significant Sparse Polygenic Risk Scores across 813 traits in UK Biobank</title><link>https://tanigawalab.org/publications/2022/prsmap/</link><pubDate>Thu, 24 Mar 2022 00:00:00 +0000</pubDate><guid>https://tanigawalab.org/publications/2022/prsmap/</guid><description>&lt;p&gt;We performed a systematic assessment of the predictive performance of PRS models across &amp;gt;1,500 traits in UK Biobank and report 813 PRS models with significant predictive performance.&lt;/p&gt;</description></item><item><title>Genetics of 35 blood and urine biomarkers in the UK Biobank</title><link>https://tanigawalab.org/publications/2021/biomarkers/</link><pubDate>Wed, 07 Apr 2021 00:00:00 +0000</pubDate><guid>https://tanigawalab.org/publications/2021/biomarkers/</guid><description>&lt;p&gt;
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/2021/biomarkers/biomarkers-1.jpg" alt="Biobank-GWAS Analysis" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
Through UK Biobank-wide GWAS meta-analysis, we report &amp;gt; 10,000 GWAS associations (p &amp;lt; 5e-9) across 35 biomarkers and &amp;gt;5,700 loci. This includes &amp;gt; 450 large-effect (&amp;gt;0.1 s.d.) associations on protein-altering variants, which we highlight in a Fuji plot (gene symbols).
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/2021/biomarkers/biomarkers-2.jpg" alt="Biobank-GWAS Analysis" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/2021/biomarkers/biomarkers-3.jpg" alt="Biobank-GWAS Analysis" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
With FINEMAP, we identified &amp;gt;27,000 distinct signals in &amp;gt;5,000 regions across the 35 traits, of which &amp;gt;2,500 signals were fine-mapped to a single variant. We also trained sparse polygenic risk score (PRS) models with Lasso L1- penalized regression using the snpnet package.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/2021/biomarkers/biomarkers-4.jpg" alt="Biobank-GWAS Analysis" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
To investigate the influence of the identified genetic basis on diseases, we performed single-variant PheWAS, PRS-PheWAS, and causal inference. Motivated by those results, we developed multi-PRS by combining a single-trait PRS model of disease with that of 35 biomarkers.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/2021/biomarkers/biomarkers-5.jpg" alt="Biobank-GWAS Analysis" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
When we compare the predictive performance, multi-PRS showed improvements over single-trait snpnet PRS across many diseases, which we also replicated in FinnGen, suggesting both large case numbers and multi-trait modeling might complementarily contribute to improving the power.&lt;/p&gt;
&lt;p&gt;This work was led by Nasa Sinnott-Armstrong, myself, and Dr. Manuel A. Rivas, with many contributions from colleagues. We thank UK Biobank, FinnGen, their participants, amazing collaborators, and colleagues, as well as funding.&lt;/p&gt;</description></item><item><title>Global Biobank Engine: enabling genotype-phenotype browsing for biobank summary statistics</title><link>https://tanigawalab.org/publications/2019/gbe/</link><pubDate>Wed, 05 Dec 2018 00:00:00 +0000</pubDate><guid>https://tanigawalab.org/publications/2019/gbe/</guid><description>&lt;p&gt;We present &lt;a href='https://gbe.stanford.edu' target='_blank'&gt;Global Biobank Engine&lt;/a&gt; as a platform to visualize genome- and phenome-wide associations and perform statistical inference using those association data.&lt;/p&gt;</description></item></channel></rss>